摘要
采用PCR技术分别从人全血基因组DNA及引产胚胎肾组织cDNA中扩增得到gpr81的全长cDNA序列(1041bp),运用生物信息学手段绘制该基因的分子进化树,显示该基因的氨基酸序列与烟酸受体同源性最高;然后,采用RT-PCR法分析该基因表达的组织分布,组织表达谱显示该基因在多种组织均有表达,以心脏及肝脏组织为最高;利用分子克隆手段构建含6×组氨酸(His)标签蛋白的真核表达载体pcDNA3·1(-)/his-myc-A-gpr81,通过脂质体介导,将该重组质粒转染CHO-K1细胞,RT-PCR证实该基因已整合入CHO-K1细胞的基因组中,Western-blot表明GPR81在CHO-GPR81工程细胞株中有表达。组织表达谱的检测和工程细胞株的建立为进一步研究该受体的生物学功能奠定了基础。
The gpr81 was amplified by polymerase chain reaction (PCR) using human fetus kidney cDNA and whole blood genome DNA as template, respectively. The expression profile of gpr81 in human fetus was analyzed by RT-PCR and the result indicated GPR81 mRNA was most abundant in fetus liver and heart. In addition, the deduced amino acid of GPR81 was compared with other related molecules by Clustal w/x software, and a molecular phylogenetic tree was constructed with Treeview software. It was showed that GPR81 had the highest homology with nicotinic acid receptor in amino acids. After sequence identification, gpr81 was inserted into the plasmid pcDNA3.1 (-)/his-mycA and then transfected into Chinese hamster ovary cell ( CHO-K1 ). With the selection of G418, an engineered cell line which could stably express gpr81 was obtained by the indication of RT-PCR and Western-blot detection. The establishment of the cell llne will serve as means for further study of GPR81.
出处
《生物工程学报》
CAS
CSCD
北大核心
2006年第3期408-412,共5页
Chinese Journal of Biotechnology
基金
国家自然科学基金(N0.30171096)
全军"十五"医药卫生基金(No.01MB056)资助项目~~